Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 2nd July 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Horse health experts issue advice on worm control
Equitape is the only licenced product for horses containing praziquantel as a single active ingredient.

Equitape is to be discontinued from October 2018

Horse health professionals have issued best practice advice on managing worm burdens following news that Equitape is to be discontinued from sale in the UK.

In a joint press release, Westgate Laboratories, Austin Davis Biologics and Professor Jacqui Matthews of the Moredon Research Institute stressed the increasing importance of evidence-based control.

“Wherever possible, we must look to reduce infection risk and break the lifecycle of the worms without overly relying on wormers,”explained Professor Matthews.

“Best practice control should include the following; strategic treatments, targeted (diagnostic test led) treatments, annual tests for wormer resistance, good pasture hygiene such as poo picking and implementing appropriate quarantine procedures for new horses.”

Equitape is the only licenced product for horses containing praziquantel as a single active ingredient. From October 2018, it will only be available in ‘combination wormers’ also containing either ivermectin or moxidectin, the drugs most commonly used to treat small and large redworm.

The researchers state that regular testing should be the focus of any programme to find out if worming treatment is needed to minimise exposure. Worm egg counts should be carried out every two to three months and tapeworm tests every six months, the press release adds.

Consultant vet to Westgate Labs, Carolyn Cummins commented: “With reduced specificity of treatment options, we are concerned that the temptation could be to treat more and test less. However with resistance rising, the only way of identifying problems is by testing routinely, together with resistance testing, to build up a picture of what’s going on.

“Giving a wormer without understanding the worm burden present or without being aware of the efficacy of the wormer you’re using is a false economy for your horse’s health.”

Image (C) Westgate Laboratories

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.